Oncology is a branch of science that investigates cancer cells. The oncology devices market includes medical devices that help within the diagnosing and treating of cancer diseases. Cancer screening and detection at an early stage are crucial for the successful treatment of cancer. Growth of the oncology devices market is majorly driven by rise in demand for these devices from the ever-growing range of patients affected with differing kinds of cancer, such as, breast, colorectal, and lung cancer. However, high price of oncology devices, stringent approval processes required for products, and side-effects of the therapy, like local swelling, local bruising, and etc. are anticipated to hamper the worldwide medicine devices market within the next few years.
The global oncology devices market is expected to be around US$ 300 billion in 2028 at a compound annual growth rate (CAGR) of 18%
Growth in cancer population and accessibility of favorable reimbursement policies for diagnosis of cancer are the key factors anticipated to drive the oncology devices market. Increase in prevalence of cancer among the tobacco-consuming population and rise in adoption of advanced diagnostic tools in the health care are anticipated to fuel the oncology devices market in the region throughout the forecast period… Rise in disposable income of individuals, growing incidence of cancer and availability of modern diagnostic procedures, and favorable health care infrastructure are likely to enhance the oncology devices market throughout the forecast period.
Market Insights
The global Oncology Devices market is segregated on the basis of Application as Cancer Research Institutes and Cancer Hospitals. Based on Diagnosis the global Oncology Devices market is segmented in Biopsy, Imaging, Endoscopy, and Blood Tests. Based on Therapeutic the global Oncology Devices market is segmented in Chemotherapy, Hormone therapy, Biotherapy, and Radiation therapy.
The global Oncology Devices market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Oncology Devices market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
GE Healthcare, Medtronic, Varian Medical Systems, Elekta, Theragenics Corporation, Accuray, Elekta, Theragenics Corporation, Eckert & Ziegler BEBIG, Accuray, and others are among the major players in the global Oncology Devices market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Oncology Devices Market has been segmented as below:
Oncology Devices Market, By Application
Oncology Devices Market, By Diagnosis
Oncology Devices Market, By Therapeutic
Oncology Devices Market, By Region
Oncology Devices Market, By Company
The report covers:
Report Scope:
The global Oncology Devices market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Oncology Devices market share. Major industry players with significant revenue share include GE Healthcare, Medtronic, Varian Medical Systems, Elekta, Theragenics Corporation, Accuray, Elekta, Theragenics Corporation, Eckert & Ziegler BEBIG, Accuray, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Breast Lesion Guidance Systems Market
Advanced Parenteral Drug Delivery Devices Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Oncology Devices Market, By Application
5.1 Introduction
5.2 Cancer Research Institutes
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Cancer Hospitals
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6. Oncology Devices Market, By Diagnosis
6.1 Introduction
6.2 Biopsy
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Imaging
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Endoscopy
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Blood Tests
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Oncology Devices Market, By Therapeutic
7.1 Introduction
7.2 Chemotherapy
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Hormone therapy
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Biotherapy
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Radiation therapy
7.5.1 Market Overview
7.5.2 Market Size and Forecast
8. Oncology Devices Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Oncology Devices, By Application
8.2.2 North America Oncology Devices, By Diagnosis
8.2.3 North America Oncology Devices, By Therapeutic
8.3 Europe
8.3.1 Europe Oncology Devices, By Application
8.3.2 Europe Oncology Devices, By Diagnosis
8.3.3 Europe Oncology Devices, By Therapeutic
8.4 Asia-Pacific
8.4.1 Asia-Pacific Oncology Devices, By Application
8.4.2 Asia-Pacific Oncology Devices, By Diagnosis
8.4.3 Asia-Pacific Oncology Devices, By Therapeutic
8.5 Rest of the World
8.5.1 Rest of the World Oncology Devices, By Application
8.5.2 Rest of the World Oncology Devices, By Diagnosis
8.5.3 Rest of the World Oncology Devices, By Therapeutic
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 GE Healthcare
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Medtronic
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Varian Medical Systems
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Elekta
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Theragenics Corporation
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Accuray
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Elekta
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Theragenics Corporation
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Eckert & Ziegler BEBIG
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Accuray
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The Oncology Devices Market has been segmented as below:
Oncology Devices Market, By Application
Oncology Devices Market, By Diagnosis
Oncology Devices Market, By Therapeutic
Oncology Devices Market, By Region
Oncology Devices Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
